A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer

Breast cancer (BC) occurs in the epithelial tissues of the breast gland, which is the most common cancer in women. This study is implemented to construct a risk score system for BC. The methylation data of BC from The Cancer Genome Atlas database (the training set) and GSE37754 from Gene Expression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer biotherapy & radiopharmaceuticals 2022-10, Vol.37 (8), p.697-707
Hauptverfasser: Sun, Ying, Wang, Rengui
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 707
container_issue 8
container_start_page 697
container_title Cancer biotherapy & radiopharmaceuticals
container_volume 37
creator Sun, Ying
Wang, Rengui
description Breast cancer (BC) occurs in the epithelial tissues of the breast gland, which is the most common cancer in women. This study is implemented to construct a risk score system for BC. The methylation data of BC from The Cancer Genome Atlas database (the training set) and GSE37754 from Gene Expression Omnibus database (the validation set) were downloaded. The differentially methylated RNAs (DMRs) between BC and normal samples were screened by limma package, and the correlations between the expression levels and methylation levels of the DMRs were analyzed to calculate their Pearson correlation coefficients (PCCs) using the cor.test function. To build the risk score system, the optimal RNAs were identified by penalized package. Subsequently, the nomogram survival model was established using the rms package. The lncRNA-mRNA comethylation network was constructed by Cytoscape software, and then enrichment analysis was performed using DAVID tool. From the 1170 DMRs between BC and normal samples, 800 DMRs with significant negative PCCs were screened. For building the risk score system, the 15 optimal RNAs were selected. Afterward, the nomogram survival model based on four independent clinical prognostic factors (including age, radiation therapy, tumor recurrence, and RS model status) was constructed. In the comethylation network, the long noncoding RNA (lncRNA) was comethylated with and . For the mRNAs in the comethylation network, angiogenesis and pathways in cancer were enriched. The risk score system and the nomogram survival model might be of great importance for the prognosis prediction of BC patients.
doi_str_mv 10.1089/cbr.2020.4074
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1089_cbr_2020_4074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33571027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-4f5a4e31faf8228ad573ef246bc36b209181bf3734e5dd6f34335f9de5042edf3</originalsourceid><addsrcrecordid>eNo9kFtLw0AQhRdRrFYffZX5A6mzt-zmsS3eoFpo9TlssrM02jZlNwr996ZUfZoz8HE4fIzdcBxxtMVdXcWRQIEjhUadsAuutcms1eK0z2hVVhirB-wypQ9EzDE352wgpTYchblg8zEsmvQJy7qNBMt96mgDE5fIQ7uFbkXwQt1qv3Zd0_8z-qZ1gjYA17B4HSdotjCJ5FIHU7etKV6xs-DWia5_75C9P9y_TZ-y2fzxeTqeZbUoZJepoJ0iyYMLVgjrvDaSglB5Vcu8Elhwy6sgjVSkvc-DVP3kUHjSqAT5IIcsO_bWsU0pUih3sdm4uC85lgcxZS-mPIgpD2J6_vbI776qDfl_-s-E_AEJN1zV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer</title><source>Alma/SFX Local Collection</source><creator>Sun, Ying ; Wang, Rengui</creator><creatorcontrib>Sun, Ying ; Wang, Rengui</creatorcontrib><description>Breast cancer (BC) occurs in the epithelial tissues of the breast gland, which is the most common cancer in women. This study is implemented to construct a risk score system for BC. The methylation data of BC from The Cancer Genome Atlas database (the training set) and GSE37754 from Gene Expression Omnibus database (the validation set) were downloaded. The differentially methylated RNAs (DMRs) between BC and normal samples were screened by limma package, and the correlations between the expression levels and methylation levels of the DMRs were analyzed to calculate their Pearson correlation coefficients (PCCs) using the cor.test function. To build the risk score system, the optimal RNAs were identified by penalized package. Subsequently, the nomogram survival model was established using the rms package. The lncRNA-mRNA comethylation network was constructed by Cytoscape software, and then enrichment analysis was performed using DAVID tool. From the 1170 DMRs between BC and normal samples, 800 DMRs with significant negative PCCs were screened. For building the risk score system, the 15 optimal RNAs were selected. Afterward, the nomogram survival model based on four independent clinical prognostic factors (including age, radiation therapy, tumor recurrence, and RS model status) was constructed. In the comethylation network, the long noncoding RNA (lncRNA) was comethylated with and . For the mRNAs in the comethylation network, angiogenesis and pathways in cancer were enriched. The risk score system and the nomogram survival model might be of great importance for the prognosis prediction of BC patients.</description><identifier>ISSN: 1084-9785</identifier><identifier>EISSN: 1557-8852</identifier><identifier>DOI: 10.1089/cbr.2020.4074</identifier><identifier>PMID: 33571027</identifier><language>eng</language><publisher>United States</publisher><ispartof>Cancer biotherapy &amp; radiopharmaceuticals, 2022-10, Vol.37 (8), p.697-707</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c293t-4f5a4e31faf8228ad573ef246bc36b209181bf3734e5dd6f34335f9de5042edf3</citedby><cites>FETCH-LOGICAL-c293t-4f5a4e31faf8228ad573ef246bc36b209181bf3734e5dd6f34335f9de5042edf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33571027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Ying</creatorcontrib><creatorcontrib>Wang, Rengui</creatorcontrib><title>A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer</title><title>Cancer biotherapy &amp; radiopharmaceuticals</title><addtitle>Cancer Biother Radiopharm</addtitle><description>Breast cancer (BC) occurs in the epithelial tissues of the breast gland, which is the most common cancer in women. This study is implemented to construct a risk score system for BC. The methylation data of BC from The Cancer Genome Atlas database (the training set) and GSE37754 from Gene Expression Omnibus database (the validation set) were downloaded. The differentially methylated RNAs (DMRs) between BC and normal samples were screened by limma package, and the correlations between the expression levels and methylation levels of the DMRs were analyzed to calculate their Pearson correlation coefficients (PCCs) using the cor.test function. To build the risk score system, the optimal RNAs were identified by penalized package. Subsequently, the nomogram survival model was established using the rms package. The lncRNA-mRNA comethylation network was constructed by Cytoscape software, and then enrichment analysis was performed using DAVID tool. From the 1170 DMRs between BC and normal samples, 800 DMRs with significant negative PCCs were screened. For building the risk score system, the 15 optimal RNAs were selected. Afterward, the nomogram survival model based on four independent clinical prognostic factors (including age, radiation therapy, tumor recurrence, and RS model status) was constructed. In the comethylation network, the long noncoding RNA (lncRNA) was comethylated with and . For the mRNAs in the comethylation network, angiogenesis and pathways in cancer were enriched. The risk score system and the nomogram survival model might be of great importance for the prognosis prediction of BC patients.</description><issn>1084-9785</issn><issn>1557-8852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kFtLw0AQhRdRrFYffZX5A6mzt-zmsS3eoFpo9TlssrM02jZlNwr996ZUfZoz8HE4fIzdcBxxtMVdXcWRQIEjhUadsAuutcms1eK0z2hVVhirB-wypQ9EzDE352wgpTYchblg8zEsmvQJy7qNBMt96mgDE5fIQ7uFbkXwQt1qv3Zd0_8z-qZ1gjYA17B4HSdotjCJ5FIHU7etKV6xs-DWia5_75C9P9y_TZ-y2fzxeTqeZbUoZJepoJ0iyYMLVgjrvDaSglB5Vcu8Elhwy6sgjVSkvc-DVP3kUHjSqAT5IIcsO_bWsU0pUih3sdm4uC85lgcxZS-mPIgpD2J6_vbI776qDfl_-s-E_AEJN1zV</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Sun, Ying</creator><creator>Wang, Rengui</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221001</creationdate><title>A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer</title><author>Sun, Ying ; Wang, Rengui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-4f5a4e31faf8228ad573ef246bc36b209181bf3734e5dd6f34335f9de5042edf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Ying</creatorcontrib><creatorcontrib>Wang, Rengui</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Cancer biotherapy &amp; radiopharmaceuticals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Ying</au><au>Wang, Rengui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer</atitle><jtitle>Cancer biotherapy &amp; radiopharmaceuticals</jtitle><addtitle>Cancer Biother Radiopharm</addtitle><date>2022-10-01</date><risdate>2022</risdate><volume>37</volume><issue>8</issue><spage>697</spage><epage>707</epage><pages>697-707</pages><issn>1084-9785</issn><eissn>1557-8852</eissn><abstract>Breast cancer (BC) occurs in the epithelial tissues of the breast gland, which is the most common cancer in women. This study is implemented to construct a risk score system for BC. The methylation data of BC from The Cancer Genome Atlas database (the training set) and GSE37754 from Gene Expression Omnibus database (the validation set) were downloaded. The differentially methylated RNAs (DMRs) between BC and normal samples were screened by limma package, and the correlations between the expression levels and methylation levels of the DMRs were analyzed to calculate their Pearson correlation coefficients (PCCs) using the cor.test function. To build the risk score system, the optimal RNAs were identified by penalized package. Subsequently, the nomogram survival model was established using the rms package. The lncRNA-mRNA comethylation network was constructed by Cytoscape software, and then enrichment analysis was performed using DAVID tool. From the 1170 DMRs between BC and normal samples, 800 DMRs with significant negative PCCs were screened. For building the risk score system, the 15 optimal RNAs were selected. Afterward, the nomogram survival model based on four independent clinical prognostic factors (including age, radiation therapy, tumor recurrence, and RS model status) was constructed. In the comethylation network, the long noncoding RNA (lncRNA) was comethylated with and . For the mRNAs in the comethylation network, angiogenesis and pathways in cancer were enriched. The risk score system and the nomogram survival model might be of great importance for the prognosis prediction of BC patients.</abstract><cop>United States</cop><pmid>33571027</pmid><doi>10.1089/cbr.2020.4074</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1084-9785
ispartof Cancer biotherapy & radiopharmaceuticals, 2022-10, Vol.37 (8), p.697-707
issn 1084-9785
1557-8852
language eng
recordid cdi_crossref_primary_10_1089_cbr_2020_4074
source Alma/SFX Local Collection
title A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T01%3A29%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Risk%20Score%20System%20Based%20on%20the%20Methylation%20Levels%20of%2015%20RNAs%20in%20Breast%20Cancer&rft.jtitle=Cancer%20biotherapy%20&%20radiopharmaceuticals&rft.au=Sun,%20Ying&rft.date=2022-10-01&rft.volume=37&rft.issue=8&rft.spage=697&rft.epage=707&rft.pages=697-707&rft.issn=1084-9785&rft.eissn=1557-8852&rft_id=info:doi/10.1089/cbr.2020.4074&rft_dat=%3Cpubmed_cross%3E33571027%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33571027&rfr_iscdi=true